Genomic device maker Fluidigm has IPO hopes
Fluidigm Corp., a San Francisco-based genomic device maker, hopes to go public. The company, which attempted its first IPO during the thick of the financial crisis, earlier this month filed a shelf registration with the Securities & Exchange Commission for an initial public offering worth $86 million. Fludigm makes disposable microfluidic chips designed for single […]